-Murali Chintagumpala Researcher Activity Profile

Research Author Detailed Information 

Murali Chintagumpala Publication Rate By Year

Murali Chintagumpala has published 2 paper(s) in 2004, 1 paper(s) in 2006, 7 paper(s) in 2007, 1 paper(s) in 2008, for a total of 11 research publications in total.

Murali M Chintagumpala Author Information

LAST NAME: chintagumpala

FIRST NAME: Murali

INITIALS: m

AFFILIATION:

Papers

Murali Chintagumpala's Publication Record

1. Retinoblastoma: from bench to bedside. Year Published: 2004
Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA. rhurwitz@bcm.tmc.edu
2. Extensively necrotic retinoblastoma is associated with high-risk prognostic factors. Year Published: 2006
Department of Ophthalmology, Baylor College of Medicine, Houston, Tex, USA.
3. A single institution experience with pediatric nasopharyngeal carcinoma: high incidence of toxicity associated with platinum-based chemotherapy plus IMRT. Year Published: 2007
Center for Cell and Gene Therapy, Baylor College of Medicine, The Methodist Hospital, Houston, TX, USA.
4. Topotecan is active against Wilms' tumor: results of a multi-institutional phase II study. Year Published: 2007
St Jude Children's Research Hospital, Memphis, TN, USA.
5. FOXG1 dysregulation is a frequent event in medulloblastoma. Year Published: 2007
Department of Pathology, Texas Children's Cancer Center, Baylor College of Medicine, One Baylor Plaza, Rm. 286A, Houston, TX 77030, USA. aadesina@bcm.tmc.edu
6. Retinoblastoma: review of current management. Year Published: 2007
Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA. mxchinta@txccc.org
7. Retinoblastoma: review of current management. Year Published: 2007
Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, USA. mxchinta@txccc.org
8. Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival. Year Published: 2007
Department of Pathology, Baylor College of Medicine, One Baylor Plaza, Houston, TX, 77030, USA, aadesina@bcm.tmc.edu.
9. Retinoblastoma: from bench to bedside. Year Published: 2004
Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA. rhurwitz@bcm.tmc.edu
10. Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival. Year Published: 2007
Department of Pathology, Baylor College of Medicine, One Baylor Plaza, Houston, TX 77030, USA. takei327@aol.com
11. Results of treatment of patients with superficial facial rhabdomyosarcomas on protocols of the Intergroup Rhabdomyosarcoma Study Group (IRSG), 1984-1997. Year Published: 2008
Division of Pediatrics and Children's Cancer Hospital, University of Texas M.D. Anderson Cancer Center, Houston, Texas, USA. rbraney@austin.rr.com